Botanix Pharmaceuticals Ltd - Asset Resilience Ratio

Latest as of June 1996: 6.42%

Botanix Pharmaceuticals Ltd (BOT) has an Asset Resilience Ratio of 6.42% as of June 1996. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Check BOT PP&E to net assets ratio to assess the company's strategic physical and investment asset allocation.

Liquid Assets

AU$3.66 Million

≈ $2.59 Million USD Cash + Short-term Investments

Total Assets

AU$57.05 Million

≈ $40.36 Million USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (1992–2019)

This chart shows how Botanix Pharmaceuticals Ltd's Asset Resilience Ratio has changed over time. See BOT equity to assets ratio to measure how much of total assets are equity-financed.

Liquid Assets Composition Over Time

This chart breaks down Botanix Pharmaceuticals Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see BOT market cap.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	AU$0.00	0%
Short-term Investments	AU$3.66 Million	6.42%
Total Liquid Assets	AU$3.66 Million	6.42%

Asset Resilience Insights

Limited Liquidity: Botanix Pharmaceuticals Ltd maintains only 6.42% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

Botanix Pharmaceuticals Ltd Industry Peers by Asset Resilience Ratio

Compare Botanix Pharmaceuticals Ltd's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Ascendis Pharma AS NASDAQ:ASND	Biotechnology	0.00%
Biomarin Pharmaceutical Inc NASDAQ:BMRN	Biotechnology	0.00%
Spyre Therapeutics Inc. NASDAQ:SYRE	Biotechnology	84.34%
3SBio Inc F:83B	Biotechnology	10.64%
Soleno Therapeutics Inc NASDAQ:SLNO	Biotechnology	20.15%
Jiangxi Fushine Pharmaceutical Co Ltd SHE:300497	Biotechnology	0.02%
Novavax Inc NASDAQ:NVAX	Biotechnology	53.87%
BB Biotech AG SW:BION	Biotechnology	0.05%

Annual Asset Resilience Ratio for Botanix Pharmaceuticals Ltd (1992–2019)

The table below shows the annual Asset Resilience Ratio data for Botanix Pharmaceuticals Ltd.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2019-06-30	0.00%	AU$0.00 ≈ $0.00	AU$5.20 Million ≈ $3.68 Million	--
2018-06-30	0.12%	AU$20.44K ≈ $14.46K	AU$17.71 Million ≈ $12.53 Million	--
2017-06-30	0.00%	AU$0.00 ≈ $0.00	AU$5.91 Million ≈ $4.18 Million	--
2016-06-30	0.00%	AU$0.00 ≈ $0.00	AU$3.70 Million ≈ $2.62 Million	--
1996-06-30	6.42%	AU$3.66 Million ≈ $2.59 Million	AU$57.05 Million ≈ $40.36 Million	+3.42pp
1995-06-30	3.00%	AU$2.04 Million ≈ $1.45 Million	AU$68.16 Million ≈ $48.23 Million	-0.61pp
1994-06-30	3.61%	AU$1.75 Million ≈ $1.24 Million	AU$48.56 Million ≈ $34.36 Million	+0.27pp
1993-06-30	3.34%	AU$1.27 Million ≈ $897.90K	AU$38.03 Million ≈ $26.91 Million	-2.04pp
1992-06-30	5.38%	AU$1.40 Million ≈ $987.05K	AU$25.92 Million ≈ $18.34 Million	--

pp = percentage points

About Botanix Pharmaceuticals Ltd

AU:BOT Australia Biotechnology

Market Cap

$30.68 Million

AU$43.35 Million AUD

Market Cap Rank

#23747 Global

#925 in Australia

Share Price

AU$0.02

Change (1 day)

-4.35%

52-Week Range

AU$0.02 - AU$0.34

All Time High

AU$0.52